跳至主要内容
临床试验/CTRI/2020/02/023456
CTRI/2020/02/023456尚未招募未知

comparison of effects of noradrenaline and phenylephrine on maternal hemodynamics and fetal well being after subarchnoid block for elective caesarean section-a randomised control trial

RAINBOW CHILDRENS HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Singleton pregnancy
  • Elective caesarean section

排除标准

  • 1.Hypertensive disorders of pregnancy
  • 2.Placental abnormalities like placenta acreta, central placenta previa
  • 3.Anticipated massive blood loss
  • 4.Foetal abnormalities
  • 5.Parturients with allergy or hypersensitivity to phenylephrine or norepinephrine

研究者

发起方
RAINBOW CHILDRENS HOSPITA

相似试验

尚未招募
4 期
To compare the effects of drugs phenylephrine and noradrenaline on newborn babies when used for fall in blood pressure after spinal anaesthesia in Caeserean delivery
CTRI/2020/06/026239Dr Prerona Saha
进行中(未招募)
1 期
Comparison of two blood pressure stimulating drugs(phenylephrine vs. noradrenaline)on bloodflow and oxygen supply to the brain and body tissues during anesthesia in anesthetized brain tumor patientsHypotension during anesthesia for brain tumor surgeryMedDRA version: 21.0Level: LLTClassification code 10056679Term: Intraoperative hypotensionSystem Organ Class: 100000004863
EUCTR2021-006168-26-DKAarhus University Hospital, Department of Anesthesia(Bedøvelse og operation)40
进行中(未招募)
1 期
IMpact of Phenylephrine vs. norAdrenaline on systemic hemodynamics and Cerebral Tissue circulation and oxygenation in anesthetized brain tumor patients (IMPACT)low blood pressure during anesthesia
CTIS2024-515400-40-00Region Midtjylland32
已完成
4 期
Comparison of effectiveness of norepinephrine andphenylephrine when given as a single bolus dose for treatment of fall in blood pressure during planned caesarean section under spinal anaesthesia
CTRI/2016/12/007542niversity College of Medical Sciences and Guru Teg Bahadur Hospital100
尚未招募
3 期
Comparison of noradrenaline with the combination of octreotide and midodrine in the treatment of hepatorenal syndrome type 1Hepatorenal Syndrome.K76.7Hepatorenal syndrome
IRCT20230228057568N1Gorgan University of Medical Sciences50